Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $3.07 billion. The enterprise value is $2.21 billion.

Market Cap	3.07B
Enterprise Value	2.21B

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

XENE has 76.24 million shares outstanding. The number of shares has increased by 16.41% in one year.

Current Share Class	76.24M
Shares Outstanding	76.24M
Shares Change (YoY)	+16.41%
Shares Change (QoQ)	-2.58%
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	92.93%
Float	70.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.74
P/TBV Ratio	3.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.21, with a Debt / Equity ratio of 0.01.

Current Ratio	22.21
Quick Ratio	22.06
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.75% and return on invested capital (ROIC) is -21.95%.

Return on Equity (ROE)	-29.75%
Return on Assets (ROA)	-21.19%
Return on Capital (ROIC)	-21.95%
Revenue Per Employee	n/a
Profits Per Employee	-$823,892
Employee Count	259
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-446,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.63% in the last 52 weeks. The beta is 1.25, so XENE's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+33.63%
50-Day Moving Average	41.21
200-Day Moving Average	41.56
Relative Strength Index (RSI)	39.85
Average Volume (20 Days)	412,321

Short Selling Information

The latest short interest is 2.89 million, so 3.79% of the outstanding shares have been sold short.

Short Interest	2.89M
Short Previous Month	3.16M
Short % of Shares Out	3.79%
Short % of Float	4.10%
Short Ratio (days to cover)	7.75

Income Statement

Revenue	n/a
Gross Profit	-192.00M
Operating Income	-255.52M
Pretax Income	-199.34M
Net Income	-213.39M
EBITDA	-252.74M
EBIT	-255.52M
Earnings Per Share (EPS)	-$2.82

Full Income Statement

Balance Sheet

The company has $654.02 million in cash and $9.79 million in debt, giving a net cash position of $793.55 million or $10.41 per share.

Cash & Cash Equivalents	654.02M
Total Debt	9.79M
Net Cash	793.55M
Net Cash Per Share	$10.41
Equity (Book Value)	797.81M
Book Value Per Share	10.53
Working Capital	629.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-156.62M
Capital Expenditures	-2.37M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.41%
Shareholder Yield	-16.41%
Earnings Yield	-6.88%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for XENE is $57.30, which is 42.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$57.30
Price Target Difference	42.29%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2